Anne T. Gelderloos

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

Hilma J. van der Horst, A. Vera de Jonge, Ida H. Hiemstra et al. · Blood Cancer Journal · 2021 · 95 citations · Full text

Life Sciences, Immunology, Oncology +16

Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis

Lisa C. Holthof, Jort J. van der Schans, Afroditi Katsarou et al. · Clinical Cancer Research · 2021 · 56 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults

Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof et al. · Immunity & Ageing · 2024 · 30 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Hilma J. van der Horst, Anne T. Gelderloos, Martine E.D. Chamuleau et al. · Blood Advances · 2021 · 23 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Lisa C. Holthof, Arwen Stikvoort, Hilma J. van der Horst et al. · HemaSphere · 2021 · 23 citations · Full text

Medicine, Immunology, Oncology +16